BMS claims pharma's most powerful AI supercomputer. How it stacks up to Lilly's and Roche's.

Bristol Myers Squibb is expanding its AI supercomputer to eight Vera Rubin racks (576 GPUs) after saturating its existing 2024 system, making it the first life-sciences company to deploy NVIDIA's latest-generation Rubin architecture at scale. The move follows similar announcements from Eli Lilly and Roche, though BMS's system claims superior energy efficiency per megawatt and roughly 10x the inference throughput per watt of prior-generation Blackwell chips.

This Wire brief sits within Fusion42's coverage of Digital Health. Wire is Fusion42's founder-focused intelligence feed: each story is connected to the funds and startups it names — every one with a live profile on Raise or Scout — so founders can follow the capital and the momentum behind the headline rather than just the headline itself. Wire analysis is one of the live surfaces Arthur reasons over.